JOHN M GIACONA

Dr. JOHN M GIACONA

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
JGJOHN M GIACONA
JOHN M GIACONA
UPUrsa B. Petric
Ursa B. Petric
WKWeerapat Kositanurit
Weerapat Kositanurit
JWJijia Wang
Jijia Wang
SSSuzanne Saldanha
Suzanne Saldanha
WVWanpen Vongpatanasin
Wanpen Vongpatanasin
Our study provides the first direct evidence supporting the beneficial role of HDL-C and ApoA-I on enhanced skeletal muscle mitochondrial function in healthy young to middle-aged humans without cardiometabolic disease.

22 December 2023 in JACC: Advances
Verified
Journal Article
Open access
JGJOHN M GIACONA
JOHN M GIACONA
RCRicardo Chia
Ricardo Chia
WKWeerapat Kositanurit
Weerapat Kositanurit
JWJijia Wang
Jijia Wang
CAColby Ayers
Colby Ayers
WVWanpen Vongpatanasin
Wanpen Vongpatanasin
Previous studies have linked cardiovascular risk factors during midlife to cognitive function in later life. However, few studies have looked at the association between cardiac function, brain structure, and cognitive function and even less have included diverse middle-aged populations. The objective of this study was to determine associations between cardiac and brain structure and function in a multiethnic cohort of middle-aged adults. A cross-sectional study was conducted in participants of the Dallas Heart Study phase 2 (N = 1,919; 46% Black participants). Left ventricular (LV) mass, LV ejection fraction, LV concentricity, and peak systolic strain (LV Ecc) were assessed by cardiac magnetic resonance imaging. White matter hyperintensities (WMH) volume was measured by fluid attenuated inversion recovery magnetic resonance imaging. The Montreal Cognitive Assessment was used to measure cognitive functioning. Associations between cardiac and brain measures were determined using multivariable linear regression after adjusting for cardiovascular risk factors, education level, and physical activity. LV ejection fraction was associated with total Montreal Cognitive Assessment score (β = 0.06 [95% CI: 0.003-0.12], P = 0.042) and LV Ecc was associated with WMH volume (β = 0.08 [95% CI: 0.01-0.14], P = 0.025) in the overall cohort without significant interaction by race/ethnicity. Higher LV mass and concentricity were associated with larger WMH volume in the overall cohort (β = 0.13 [95% CI: 0.03-0.23], P = 0.008 and 0.10 [95% CI: 0.03-0.17], P = 0.005). These associations were more predominant in Black than White participants (β = 0.17 [95% CI: 0.04-0.30] vs β = −0.009 [95% CI: −0.16 to 0.14], P = 0.036 and β = 0.22 [95% CI: 0.13-0.32] vs β = −0.11 [95% CI: −0.21 to −0.01], P < 0.0001, for LV mass and concentricity, respectively). Subclinical cardiac dysfunction indicated by LVEF was associated with lower cognitive function. Moreover, LV mass and concentric remodeling were associated with higher WMH burden, particularly among Black individuals.

1 April 2024 in Journal of Applied Physiology
Verified
Journal Article
Closed access
JGJOHN M GIACONA
JOHN M GIACONA
AAAreeb Afridi
Areeb Afridi
UPUrsa Bezan Petric
Ursa Bezan Petric
TJTalon Johnson
Talon Johnson
JPJohanne Pastor
Johanne Pastor
WVWanpen Vongpatanasin
Wanpen Vongpatanasin
This is the first translational research study directly demonstrating the adverse effects of dietary phosphate on muscle energy metabolism in humans. Importantly, our data show that dietary phosphate is associated with impaired muscle ATP synthesis at rest and during exercise, independent of age and renal function. This is a new biologic paradigm with significant clinical dietary implications.

6 August 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
WKWeerapat Kositanurit
Weerapat Kositanurit
JGJOHN M GIACONA
JOHN M GIACONA
DXDonglu Xie
Donglu Xie
JWJijia Wang
Jijia Wang
DFDaniel Feuer
Daniel Feuer
WVWanpen Vongpatanasin
Wanpen Vongpatanasin

18 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JGJOHN M GIACONA
JOHN M GIACONA
JWJijia Wang
Jijia Wang
RZRong Zhang
Rong Zhang
BKBrendan J Kelley
Brendan J Kelley
IHIhab M. Hajjar
Ihab M. Hajjar
WVWanpen Vongpatanasin
Wanpen Vongpatanasin
Objective: High-density lipoprotein cholesterol efflux function may prevent brain amyloid beta deposition and neurodegeneration. However, the relevance of this finding has not been established in the diverse middle-aged population. Methods: We examined 1826 adults (47% Black adults) who participated in the Dallas Heart Study to determine associations between high-density lipoprotein (HDL) measures and brain structure and function. White matter hyperintensities (WMH) and whole-brain grey matter volume (GMV) were measured using brain MRI, and the Montreal Cognitive Assessment (MoCA) was used to measure neurocognitive function. HDL cholesterol efflux capacity (HDL-CEC) was assessed using fluorescence-labeled cholesterol efflux from J774 macrophages, and HDL particle size measures were assessed using nuclear magnetic resonance (NMR) spectroscopy (LipoScience). Multivariable linear regressions were performed to elucidate associations between HDL-CEC and brain and cognitive phenotypes after adjustment for traditional risk factors such as age, smoking status, time spent in daily physical activity, and education level. Results: Higher HDL-CEC and small HDL particle (HDL-P) concentration were positively associated with higher GMV normalized to total cranial volume (TCV) (GMV/TCV) after adjustment for relevant risk factors (β = 0.078 [95% CI: 0.029, 0.126], p = 0.002, and β = 0.063 [95% CI: 0.014, 0.111], p = 0.012, respectively). Conversely, there were no associations between HDL measures and WMH or MoCA (all p > 0.05). Associations of HDL-CEC and small HDL-P with GMV/TCV were not modified by ApoE-ε4 status or race/ethnicity. Interpretation: Higher HDL cholesterol efflux and higher plasma concentration of small HDL-P were associated with higher GMV/TCV. Additional studies are needed to explore the potential neuroprotective functions of HDL.

16 April 2022 in Cureus
Verified
Journal Article
Open access
JGJOHN M GIACONA
JOHN M GIACONA
MWMaxwell Weiner
Maxwell Weiner
JHJohn J Hanna
John J Hanna
TJTomasz Jodlowski
Tomasz Jodlowski
RBRoger Bedimo
Roger Bedimo
We report the fiftieth case in the literature of Pasteurella species peritoneal dialysis (PD)-related peritonitis and the third reported case of Pasteurella multocida bacteremia associated with PD-related peritonitis. Our review provides the most up-to-date collection of all fifty reported cases of PD-related peritonitis caused by Pasteurella species. A 77-year-old Caucasian male with a past medical history significant for new-onset left-ventricular systolic heart failure, severe mitral valve regurgitation, and end-stage renal disease on PD for six months presented to the emergency department with a one-week cloudy peritoneal effluent and intermittent abdominal pain. Pasteurella multocida was isolated from blood cultures and peritoneal fluid cultures. The patient was treated with intravenous piperacillin-tazobactam and intraperitoneal cefepime. The PD catheter was not removed or exchanged. A repeat blood culture on the third hospital day was negative. His hospital course was complicated by cardiogenic shock, atrial fibrillation, and gastrointestinal bleeding, and his goals of care changed to focus on comfort measures. This case report and literature review provide a resource for healthcare providers who may encounter this infection in the future. This case also serves as a reminder of the challenges of PD in patients at risk of acquired zoonotic infections from their pets. Based on the reviewed three cases of Pasteurella multocida bacteremia associated with PD-related peritonitis, blood cultures may be a prudent option for patients presenting with peritoneal dialysis associated peritonitis to ensure that concurrent bacteremia is not overlooked.